The government of Ghana has officially launched a licensing programme allowing the cultivation and management of industrial and medicinal cannabis, opening the door for companies and individuals to apply for permits.
The initiative was announced on February 26 by Muntaka Mohammed-Mubarak, who said the new system will regulate the production and processing of cannabis strictly for industrial and pharmaceutical purposes.
Under the policy, licences will cover activities such as cultivation, processing, research, laboratory testing, storage, transportation, and import or export of the plant.
Authorities also clarified that only cannabis varieties containing no more than 0.3% THC will be permitted, ensuring the programme focuses on industrial hemp and medicinal applications rather than recreational use.
Officials say the move is aimed at boosting the production of industrial fibres, seeds, and pharmaceutical products, potentially creating new opportunities for agriculture and investment.
However, the programme is already facing legal scrutiny. A farmer from Techiman, Mariam Alhassan, has filed a lawsuit at the Supreme Court of Ghana challenging the licensing framework.
Alhassan argues that the system is unconstitutional, claiming its structure unfairly excludes smallholder farmers due to high licensing fees and administrative requirements.
Reports suggest licence fees could range from $5,000 to $42,000, depending on the type of operation, which critics say may make it difficult for small-scale farmers to participate.
The ongoing court case could influence the future of Ghana’s emerging hemp industry, which many see as a potential driver of agricultural exports and foreign investment.
Post a Comment